###begin article-title 0
###xml 25 29 <span type="species:ncbi:10090">mice</span>
STAT2 hypomorphic mutant mice display impaired dendritic cell development and antiviral response
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 1102 1111 1094 1103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1185 1190 1177 1182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">were </italic>
###xml 114 118 <span type="species:ncbi:10090">mice</span>
###xml 483 487 <span type="species:ncbi:10090">mice</span>
###xml 731 736 <span type="species:ncbi:10090">mouse</span>
###xml 740 745 <span type="species:ncbi:9606">human</span>
###xml 991 995 <span type="species:ncbi:10090">mice</span>
###xml 1398 1402 <span type="species:ncbi:12104?1.0">EMCV</span>
###xml 1450 1454 <span type="species:ncbi:10090">mice</span>
Interferons (IFNs) are key regulators for both innate and adaptive immune responses. By screening ENU-mutagenized mice, we identified a pedigree- P117 which displayed impaired response to type I, but not type II, IFNs. Through inheritance test, genetic mapping and sequencing, we found a T to A point mutation in the 5' splice site of STAT2 intron 4-5, leading to cryptic splicing and frame shifting. As a result, the expression of STAT2 protein was greatly diminished in the mutant mice. Nonetheless, a trace amount of functional STAT2 protein was still detectable and was capable of inducing, though to a lesser extent, IFNalpha-downstream gene expressions, suggesting that P117 is a STAT2 hypomorphic mutant. The restoration of mouse or human STAT2 gene in P117 MEFs rescued the response to IFNalpha, suggesting that the mutation in STAT2 is most likely the cause of the phenotypes seen in the pedigree. Development of different subsets of lymphocytes appeared to be normal in the mutant mice except that the percentage and basal expression of CD86 in splenic pDC and cDC were reduced. In addition, in vitro Flt3L-dependent DC development and TLR ligand-mediated DC differentiation were also defective in mutant cells. These results suggest that STAT2 positively regulates DC development and differentiation. Interestingly, a severe impairment of antiviral state and increased susceptibility to EMCV infection were observed in the mutant MEFs and mice, respectively, suggesting that the remaining STAT2 is not sufficient to confer antiviral response. In sum, the new allele of STAT2 mutant reported here reveals a role of STAT2 for DC development and a threshold requirement for full functions of type I IFNs.
###end p 2
###begin title 3
Background
###end title 3
###begin p 4
###xml 395 396 388 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 654 655 647 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 656 657 649 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 821 822 810 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1040 1041 1029 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
Interferon (IFN)s are classified into type I, II and III according to the receptors they bind to. Type I IFNs family consists of about 20 members of IFNalpha and only one member of IFNbeta. The prominent function of type I IFNs is interfering viral infections through blocking viral transcription, degrading viral RNA, inhibiting translation and modifying proteins to control viral replication [1]. Other than antiviral responses, type I IFNs also exert different functions, including modulating innate and adaptive immunity, controlling cross presentation, promoting or impeding differentiation of certain cell types, and inhibiting cell proliferation [2,3]. Type II IFN consists of only one species of IFN- IFNgamma that is mainly produced by T and NK cells when stimulated and is critical to their effector functions [4]. Other than regulating innate and adaptive immune response, type I and II IFNs also play important roles in cancer immunosurveillance and immunoediting, which place IFNs in a critical position in anticancer therapy [5].
###end p 4
###begin p 5
###xml 68 69 68 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 760 768 749 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 924 925 913 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 926 927 915 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1013 1014 1002 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1239 1241 1228 1230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1242 1244 1231 1233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1368 1370 1357 1359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1580 1582 1569 1571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1583 1585 1572 1574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 849 853 <span type="species:ncbi:10090">mice</span>
###xml 855 859 <span type="species:ncbi:10090">Mice</span>
###xml 940 944 <span type="species:ncbi:10090">mice</span>
###xml 1007 1011 <span type="species:ncbi:10090">mice</span>
###xml 1219 1223 <span type="species:ncbi:10090">mice</span>
Signal transduction of IFNs is mainly mediated by JAK-STAT pathway [6]. The binding of IFNalpha/beta to IFNAR1 and IFNAR2 leads to activation of JAK1 and TYK2 followed by activation of STAT1, STAT2 and STAT3. STAT1, STAT2 and IRF9 form hetero-trimer, bind to interferon stimulated responsible element (ISRE) and transactivate downstream genes. STAT1 and STAT3 can also form homo- or hetero-dimers and bind to gamma activated site (GAS) to induce a different set of genes. Likewise, when IFNgamma binds to IFNGR1 and IFNGR2, JAK1 and JAK2 are activated, which in turn activate STAT1. Activated STAT1 forms dimers and translocates into nucleus where the dimmer binds to GAS element in the promoter region of IFNg-inducible genes and trigger transactivation. The in vivo roles of STAT1, STAT2, and STAT3 have been well established by gene targeting in mice. Mice lacking STAT1 display severe impairment of antiviral responses [7,8]. Likewise, mice lacking STAT2 also exhibit similar phenotypes seen in STAT1KO mice [9], implying a pivotal role of STAT1 and/or STAT2 in response to viral infection. Other than impaired antiviral response, the functions of several immune cells including NK and B cells are also affected in mice lacking STAT1 [10,11]. Conventional knockout of STAT3 leads to early embryonic lethality, implying that STAT3 is developmentally indispensible [12]. However, using Cre-loxP system to induce STAT3 deletion in different tissues or organs unveils multiple functions of STAT3, ranging from cell survival, apoptosis, migration, development and differentiation [13-16].
###end p 5
###begin p 6
###xml 465 474 465 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
###xml 478 486 478 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
###xml 74 78 <span type="species:ncbi:10090">P117</span>
###xml 537 541 <span type="species:ncbi:10090">P117</span>
###xml 571 575 <span type="species:ncbi:10090">P117</span>
###xml 576 580 <span type="species:ncbi:10090">mice</span>
###xml 589 593 <span type="species:ncbi:10090">mice</span>
In this study, we identified and characterized a pedigree of mutant mice (P117) which displayed impaired response to type I, but not type II, IFNs. A T to A point mutation in the 5' splice site of STAT2 intron 4-5 resulted in cryptic splicing and frame shift, leading to diminished production of STAT2 protein. Nonetheless, a small amount of STAT2 was detectable and remained functional, suggesting the STAT2 mutation results in hypomorphic and not null phenotype. In vitro and in vivo assays showed that DC development was defective in P117. Moreover, MEFs derived from P117 mice and the mice were extremely susceptible to viral infections, suggesting that the remaining STAT2 was not sufficient to confer antiviral response.
###end p 6
###begin title 7
Results
###end title 7
###begin title 8
Pedigree 117 displays impaired IFNalpha response
###end title 8
###begin p 9
###xml 190 192 190 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 193 195 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 928 930 916 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 1153 1155 1133 1135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 1250 1252 1226 1228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 103 107 <span type="species:ncbi:10090">mice</span>
###xml 224 228 <span type="species:ncbi:10090">mice</span>
###xml 358 362 <span type="species:ncbi:10090">mice</span>
###xml 524 528 <span type="species:ncbi:10090">mice</span>
###xml 650 654 <span type="species:ncbi:10090">mice</span>
###xml 813 817 <span type="species:ncbi:10090">mice</span>
###xml 852 856 <span type="species:ncbi:10090">P117</span>
###xml 942 946 <span type="species:ncbi:10090">P117</span>
###xml 1234 1238 <span type="species:ncbi:10090">P117</span>
###xml 1239 1243 <span type="species:ncbi:10090">mice</span>
###xml 1306 1310 <span type="species:ncbi:10090">P117</span>
Forward genetics or phenotype-driven approach using N-ethyl-N-nitrosourea (ENU) to induce mutations in mice provides a unique opportunity to assign functions to genes in an unbiased manner [17,18]. To screen ENU-mutagenized mice with defective IFN signaling, we designed a two-step screening method. The first step was to stimulate PBLs from ENU-mutagenized mice with IFNalpha or IFNgamma, followed by measuring the surface expression of MHC class I and ICAM-1, molecules downstream of IFNs, by flow cytometry. Once deviant mice with enhanced or reduced IFN response were identified, a second confirmation step was performed. The PBLs of the deviant mice were stimulated with IFNs and the expressions of IP-10, OAS, PKR and SOCS1, four IFN-inducible genes were quantified by RT-QPCR. After screening some 2800 G3 mice from 134 pedigrees, we identified P117 as a poor IFNalpha responder to be of great interest. As shown in Fig. 1A, PBLs from P117 stimulated by IFNalpha expressed low levels of MHC class I and ICAM-1 as compared with wild-type controls. Likewise, the expressions of IFNalpha-inducible IP-10, OAS and PKR were also greatly reduced (Fig. 1B). However, IFNgamma-induced IP-10 and SOCS-1 expressions were not affected in P117 mice (Fig. 1B). These results suggest that ENU-induced mutation in P117 is specific to IFNalpha signaling pathway.
###end p 9
###begin p 10
###xml 0 41 0 37 <bold xmlns:xlink="http://www.w3.org/1999/xlink">P117 displayed impaired IFN&#945; response</bold>
###xml 0 4 <span type="species:ncbi:10090">P117</span>
###xml 71 75 <span type="species:ncbi:10090">mice</span>
###xml 259 263 <span type="species:ncbi:10090">mice</span>
###xml 662 666 <span type="species:ncbi:10090">P117</span>
P117 displayed impaired IFNalpha response. (A) PBLs of ENU-mutagenized mice were stimulated without or with IFNalpha 1000 U/ml for 21 h followed by staining with antibodies to MHC class I and ICAM-1 and analyzed by flow cytometry. (B) PBLs of ENU-mutagenized mice were stimulated with IFNgamma 500 ng/ml or IFNalpha 1000 U/ml for 3 h followed by preparation of mRNA for RT-QPCR using primers to IP-10 (IFNgamma and IFNalpha), SOCS1 (IFNgamma), OAS (IFNalpha) and PKR (IFNalpha). Stimulation index was calculated as described in the Materials and Methods. Relative mRNA was shown by normalizing the values of specific genes to that of beta-actin. Arrow heads are P117.
###end p 10
###begin title 11
###xml 27 31 <span type="species:ncbi:10090">P117</span>
The mutation introduced to P117 is recessive and linked to Chromosome 10
###end title 11
###begin p 12
###xml 202 204 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 45 49 <span type="species:ncbi:10090">P117</span>
###xml 67 71 <span type="species:ncbi:10090">P117</span>
###xml 143 147 <span type="species:ncbi:10090">P117</span>
###xml 314 318 <span type="species:ncbi:10090">P117</span>
###xml 382 386 <span type="species:ncbi:10090">mice</span>
###xml 428 432 <span type="species:ncbi:10090">mice</span>
###xml 494 498 <span type="species:ncbi:10090">mice</span>
###xml 609 613 <span type="species:ncbi:10090">mice</span>
###xml 637 641 <span type="species:ncbi:10090">mice</span>
###xml 678 682 <span type="species:ncbi:10090">mice</span>
To study if the reduced IFNalpha response in P117 was inheritable, P117 was first crossed with one of its siblings. Interestingly, a number of P117 offspring showed hyporesponsiveness to IFNalpha (Fig. 2A) which suggests the phenotype is inheritable. We next determined if the phenotype was recessive or dominant. P117 (in C57BL/6 background) was first crossed to wild type C57BL/6 mice. No aberrant response was observed in F1 mice. However, the phenotype reappeared in the F1-intercrossed F2 mice, suggesting that the aberrant IFNalpha response was recessive. To further confirm this finding, we crossed F1 mice with wild-type C57BL/6 mice and the phenotype disappeared in F2 mice. Together, the results of the inheritance test suggest that the altered IFNalpha response was recessive.
###end p 12
###begin p 13
###xml 0 58 0 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Mutation in P117 was recessive and linked to chromosome 10</bold>
###xml 755 757 749 751 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 766 767 758 759 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 12 16 <span type="species:ncbi:10090">P117</span>
###xml 69 73 <span type="species:ncbi:10090">P117</span>
###xml 120 124 <span type="species:ncbi:10090">P117</span>
###xml 175 179 <span type="species:ncbi:10090">P117</span>
###xml 203 207 <span type="species:ncbi:10090">mice</span>
###xml 224 228 <span type="species:ncbi:10090">mice</span>
###xml 263 267 <span type="species:ncbi:10090">mice</span>
###xml 317 321 <span type="species:ncbi:10090">mice</span>
###xml 369 373 <span type="species:ncbi:10090">mice</span>
###xml 403 407 <span type="species:ncbi:10090">mice</span>
###xml 695 699 <span type="species:ncbi:10090">mice</span>
Mutation in P117 was recessive and linked to chromosome 10. (A) When P117 crossed with one of its siblings, a number of P117 offspring showed impaired IFNalpha response. When P117 crossed with wild-type mice, none of the F1 mice showed the phenotype. When the F1 mice intercrossed, the phenotype reappeared in the F2 mice. However, the phenotype was not observed in F2 mice of F1 crossed with wild-type mice. Empty squares and circles are unaffected males and females, respectively. Solid squares and circles are affected males and females, respectively. (B) Haplotype analysis was done as described in the Materials and Methods. The physical linkage of the mutation to chromosome in the mutant mice was based on the percentage of the maximum possible chi2 (%max chi2). Solid bar: linked loci. Empty bars: unlinked loci.
###end p 13
###begin p 14
###xml 148 150 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 463 465 459 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 531 532 525 526 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 177 182 <span type="species:ncbi:10090">mouse</span>
###xml 282 286 <span type="species:ncbi:10090">mice</span>
###xml 298 302 <span type="species:ncbi:10090">mice</span>
###xml 381 385 <span type="species:ncbi:10090">mice</span>
To identify that the mutation accounts for the aberrant response to IFNalpha, we first performed genetic mapping using interval haplotype analysis [19]. First, G3 affected male mouse was mated with C3H/HeJ females to generate F1 offspring that were then intercrossed to generate F2 mice. Of 292 F2 mice, 70 (~24%) were affected. DNA samples obtained from 15 individual affected F2 mice were subjected to interval haplotype analysis. The results are shown in Fig. 2B. Based on the percentage of maximum possible Chi square (%max chi2) value, linkage of the mutant gene was assigned to chromosome 10.
###end p 14
###begin title 15
###xml 42 46 <span type="species:ncbi:10090">P117</span>
STAT2 protein expression is diminished in P117
###end title 15
###begin p 16
###xml 506 508 494 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 6 10 <span type="species:ncbi:10090">P117</span>
###xml 426 430 <span type="species:ncbi:10090">P117</span>
###xml 495 499 <span type="species:ncbi:10090">mice</span>
###xml 579 583 <span type="species:ncbi:10090">P117</span>
###xml 584 588 <span type="species:ncbi:10090">mice</span>
###xml 625 629 <span type="species:ncbi:10090">mice</span>
###xml 867 871 <span type="species:ncbi:10090">mice</span>
Since P117 selectively displayed reduced response to IFNalpha but not IFNgamma, we reasoned that the affected molecule might be one of the signal mediators specific to IFNalpha such as IFNAR1, IFNAR2, Tyk2, or STAT2. We first examined the expression of STATs and phospho-STATs in cells after stimulation with IFNs. Western blot analysis showed that while the protein levels of STAT1 and STAT3 were comparable in wild-type and P117 splenocytes, the STAT2 protein was not detectable in the mutant mice (Fig. 3A). Likewise, the levels of STAT1 and STAT3 tyrosine phosphorylation in P117 mice were also comparable with wild-type mice; yet IFNalpha-induced pSTAT2 (Tyr689) was completely undetectable in mutant cells. Immunohistochemical staining also showed that although STAT2 protein was expressed in different organs, including liver, kidney and the lung of wild-type mice, its expression in p117 was greatly reduced (data not shown).
###end p 16
###begin p 17
###xml 0 124 0 124 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A T to A point mutation in 5' splice site of the STAT2 intron 4&#8211;5 resulted in diminished expression of STAT2 protein in P117</bold>
###xml 758 762 747 751 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/m </sup>
###xml 783 787 772 776 <sup xmlns:xlink="http://www.w3.org/1999/xlink">m/m </sup>
###xml 940 944 925 929 <sup xmlns:xlink="http://www.w3.org/1999/xlink">m/m </sup>
###xml 120 124 <span type="species:ncbi:10090">P117</span>
###xml 158 162 <span type="species:ncbi:10090">P117</span>
###xml 163 167 <span type="species:ncbi:10090">mice</span>
###xml 397 401 <span type="species:ncbi:10090">P117</span>
###xml 566 571 <span type="species:ncbi:10090">mouse</span>
###xml 788 792 <span type="species:ncbi:10090">P117</span>
###xml 807 811 <span type="species:ncbi:10090">mice</span>
###xml 945 949 <span type="species:ncbi:10090">P117</span>
A T to A point mutation in 5' splice site of the STAT2 intron 4-5 resulted in diminished expression of STAT2 protein in P117. (A) Splenocytes of wild-type or P117 mice were stimulated with IFNgamma or IFNalpha for 0, 3 and 6 h followed by Western blotting using antibodies to pSTAT1, STAT1, pSTAT2, STAT2, pSTAT3, STAT3 and beta-actin. (B) Genomic sequencing results of wild-type (left panels) or P117 (middle panels). cDNA sequencing of p117 (right panels) indicated the addition of 5 nucleotides between exon 4 and exon 5. Schematic diagram of the mutation in the mouse STAT2 protein was shown (lower panel). PI: protein interaction, DBD: DNA binding domain, SH2: src homology 2, TAD: transactivation domain (C) Splenocytes of wild-type (empty bars), STAT2+/m (gray bars) and STAT2m/m (P117) (solid bars) mice were stimulated with IFNalpha (250 U/ml) for 0, 3 and 6 h, followed by RT-QPCR for OAS gene expression. Inset: response in STAT2m/m (P117) cells in a smaller scale. Western blotting was done using antibody to STAT2. Arrow head indicated full length STAT2. Relative mRNA was shown by normalizing the values of OAS to that of beta-actin.
###end p 17
###begin p 18
###xml 232 234 232 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 572 574 568 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 674 676 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 845 847 841 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 1150 1154 1142 1146 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/m </sup>
###xml 1163 1167 1155 1159 <sup xmlns:xlink="http://www.w3.org/1999/xlink">m/m </sup>
###xml 1197 1199 1189 1191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 1285 1288 1277 1280 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/m</sup>
###xml 1877 1879 1857 1859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 221 225 <span type="species:ncbi:10090">P117</span>
###xml 302 306 <span type="species:ncbi:10090">P117</span>
###xml 366 371 <span type="species:ncbi:10090">Mouse</span>
###xml 1049 1053 <span type="species:ncbi:10090">P117</span>
###xml 1168 1172 <span type="species:ncbi:10090">P117</span>
###xml 1174 1178 <span type="species:ncbi:10090">mice</span>
###xml 1377 1381 <span type="species:ncbi:10090">P117</span>
###xml 1592 1596 <span type="species:ncbi:10090">P117</span>
###xml 1675 1679 <span type="species:ncbi:10090">P117</span>
###xml 1918 1922 <span type="species:ncbi:10090">P117</span>
###xml 1923 1927 <span type="species:ncbi:10090">mice</span>
To further examine whether the mutation was indeed harbored in the STAT2 gene, the STAT2 genomic DNA and cDNA were sequenced. We identified a T to A point mutation in the 5' splice site of intron 4-5 of the STAT2 gene in P117 (Fig. 3B left and middle panels). The point mutation was present in all the P117 that displayed altered IFNalpha response (data not shown). Mouse STAT2 gene encodes 923 amino acids in which 5 functional domains are defined, namely protein interaction (PI), coiled-coil, DNA binding (DBD), Src homology 2 (SH2), and transactivation domains (TAD) [20]. The mutation was located in the coiled-coil domain of STAT2 close to its N-terminal region (Fig. 3B lower panel). The point mutation resulted in cryptic splicing of STAT2 mRNA by using a new 5' splice site GU located three nucleotides downstream of the mutation (Fig. 3B, right panel). The alternative splicing caused frame-shift and created stop codons which left out critical domains of STAT2 protein including DBD, SH2 and TAD. To further confirm the phenotype seen in P117, we used RT-QPCR to examine induction of OAS gene by IFNalpha in splenocytes of wild-type, STAT2+/m and STAT2m/m (P117) mice. As shown in Fig. 3C, OAS mRNA expression was dramatically reduced in the mutant cells as opposed to STAT2+/m or wild type control. Interestingly, however, we also noted that OAS gene expression in P117 cells was not completely diminished. Although the expression level following IFNalpha treatment for 6 h was approximately 1/40 of that in wild-type cells, it was still 20-fold higher than basal level of OAS in P117. These results suggest that a marginal IFNalpha response was still at work in P117 cells. In fact, at longer exposure, we observed a trace amount of full-length STAT2 protein in the mutant cells whose expression would increase further with time following IFNalpha treatment (Fig. 3C, inset). Therefore, we concluded that P117 mice were STAT2 hypomorphic instead of null mutant.
###end p 18
###begin title 19
###xml 50 54 <span type="species:ncbi:10090">P117</span>
Restoration of STAT2 rescues IFNalpha response in P117 MEFs
###end title 19
###begin p 20
###xml 292 294 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 295 297 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 533 535 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 669 671 661 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 676 678 668 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 47 51 <span type="species:ncbi:10090">P117</span>
###xml 139 143 <span type="species:ncbi:10090">P117</span>
###xml 170 175 <span type="species:ncbi:9606">human</span>
###xml 180 185 <span type="species:ncbi:10090">mouse</span>
###xml 274 279 <span type="species:ncbi:10090">mouse</span>
###xml 362 367 <span type="species:ncbi:9606">human</span>
###xml 371 376 <span type="species:ncbi:10090">mouse</span>
###xml 416 420 <span type="species:ncbi:10090">P117</span>
###xml 841 845 <span type="species:ncbi:10090">P117</span>
###xml 1040 1044 <span type="species:ncbi:10090">mice</span>
To confirm that IFNalpha hyporesponsiveness in P117 was due to mutation in STAT2 instead of elsewhere, we restored wild-type STAT2 back to P117 MEFs. It is reported that human and mouse STAT2 are divergent due to the presence of repetitive sequence in the C-terminus of the mouse STAT2 gene [20,21]. Therefore, bicistronic retroviruses carrying either wild-type human or mouse STAT2 gene and GFP were used to infect P117 MEFs. Judging from the percentage of GFP positive cells, the infection efficiency was between 46% and 61% (Fig. 4A). The infected cells were stimulated with IFNalpha followed by RT-QPCR to detect the induction of OAS and PKR mRNA. As shown in Fig. 4B and 4C, OAS and PKR were readily induced in control wild-type MEF after treatment. While transduction with vector alone did not alter IFNalpha hyporesponsiveness in the P117 MEF, restoration with hSTAT2 or mSTAT2 gene greatly rescued the inducibility of OAS and PKR by IFNalpha. These gain-of-function results suggest that the aberrant IFNalpha response in the mutant mice was due to defect in STAT2 expression.
###end p 20
###begin p 21
###xml 0 49 0 45 <bold xmlns:xlink="http://www.w3.org/1999/xlink">STAT2 gene rescued IFN&#945; response in P117 MEFs</bold>
###xml 40 44 <span type="species:ncbi:10090">P117</span>
###xml 55 59 <span type="species:ncbi:10090">P117</span>
###xml 224 228 <span type="species:ncbi:10090">P117</span>
###xml 266 271 <span type="species:ncbi:9606">human</span>
###xml 288 293 <span type="species:ncbi:10090">mouse</span>
STAT2 gene rescued IFNalpha response in P117 MEFs. (A) P117 MEFs were infected with MigR1, MigR1-hSTAT2 or MigR1-mSTAT2 recombinant retrovirus. The infection efficiency was indicated by the percentage of GFP positive cells. P117 MEFs restored with vector alone (v), human STAT2 (hST2) or mouse STAT2 (mST2) gene were left untreated (medium, empty bars) or treated with 250 U/ml IFNalpha for 3 h (solid bars) followed by RT-QPCR using primers to OAS (B) or PKR (C). Relative mRNA was shown by normalizing the values of OAS or PKR to that of beta-actin.
###end p 21
###begin title 22
###xml 0 4 <span type="species:ncbi:10090">P117</span>
P117 displays impaired DC development in vivo and in vitro
###end title 22
###begin p 23
###xml 541 543 541 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 544 546 544 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 633 635 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 640 642 640 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 686 687 686 687 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 691 692 691 692 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 708 709 708 709 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 714 715 714 715 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 760 764 760 764 <sup xmlns:xlink="http://www.w3.org/1999/xlink">m/m </sup>
###xml 790 794 790 794 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/m </sup>
###xml 854 856 854 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C</xref>
###xml 985 989 985 989 <sup xmlns:xlink="http://www.w3.org/1999/xlink">m/m </sup>
###xml 1032 1034 1032 1034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 1039 1041 1039 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 112 116 <span type="species:ncbi:10090">P117</span>
###xml 117 121 <span type="species:ncbi:10090">mice</span>
###xml 320 324 <span type="species:ncbi:10090">P117</span>
###xml 325 329 <span type="species:ncbi:10090">mice</span>
###xml 367 371 <span type="species:ncbi:10090">mice</span>
###xml 610 614 <span type="species:ncbi:10090">P117</span>
###xml 765 769 <span type="species:ncbi:10090">P117</span>
###xml 794 798 <span type="species:ncbi:10090">mice</span>
###xml 990 994 <span type="species:ncbi:10090">P117</span>
To study whether STAT2 regulates hematopoiesis, cells from bone marrow, thymus, PBL and spleen of wild-type and P117 mice were stained and subjected to flow cytometry. The percentage and numbers of T cell subsets in the thymus, B cell subsets in the bone marrow and mature CD4, CD8, and B cells in the PBL and spleen in P117 mice were comparable to that in wild-type mice, suggesting that STAT2 does not regulate the development of T or B cells (data not shown). Since type I IFNs were reported to affect the maturation and functions of DC [22,23], we further tested if there was a defect in DC development in P117. As shown in Fig. 5A and 5B, left panels, the percentages of pDC (CD11c+B220+) and cDC (CD11c+CD11b+) were greatly reduced in the spleen of STAT2m/m (P117) as opposed to STAT2+/m mice and the difference was statistically significant (Fig. 5C). The cellularity of both types of DC was also reduced in the mutant (data not shown). Likewise, the expression of CD86 on STAT2m/m (P117) pDC or cDC was also decreased (Fig. 5A and 5B, right panels).
###end p 23
###begin p 24
###xml 0 77 0 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Reduced percentage of DCs and impaired Flt3L-dependent DC development in P117</bold>
###xml 99 103 99 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/m </sup>
###xml 111 115 111 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink">m/m </sup>
###xml 219 220 219 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 224 225 224 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 244 245 244 245 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 250 251 250 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 265 269 265 269 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/m </sup>
###xml 292 296 292 296 <sup xmlns:xlink="http://www.w3.org/1999/xlink">m/m </sup>
###xml 345 349 345 349 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 458 462 458 462 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/m </sup>
###xml 484 488 484 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink">m/m </sup>
###xml 576 580 576 580 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/m </sup>
###xml 602 606 602 606 <sup xmlns:xlink="http://www.w3.org/1999/xlink">m/m </sup>
###xml 770 774 770 774 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/m </sup>
###xml 798 802 798 802 <sup xmlns:xlink="http://www.w3.org/1999/xlink">m/m </sup>
###xml 73 77 <span type="species:ncbi:10090">P117</span>
###xml 116 120 <span type="species:ncbi:10090">P117</span>
###xml 122 126 <span type="species:ncbi:10090">mice</span>
###xml 297 301 <span type="species:ncbi:10090">P117</span>
###xml 489 493 <span type="species:ncbi:10090">P117</span>
###xml 508 512 <span type="species:ncbi:10090">mice</span>
###xml 607 611 <span type="species:ncbi:10090">P117</span>
###xml 626 630 <span type="species:ncbi:10090">mice</span>
###xml 803 807 <span type="species:ncbi:10090">P117</span>
Reduced percentage of DCs and impaired Flt3L-dependent DC development in P117. Splenocytes of STAT2+/m or STAT2m/m (P117) mice were stained with antibodies to CD11c, CD86, and B220 or CD11b. The percentage of pDC (CD11c+B220+) (A) or cDC (CD11c+CD11b+) (B) in STAT2+/m (upper panels) or STAT2m/m (P117) (lower panels) and the percentage of CD86 high gated on these two populations were shown (right panels). (C) The average percentage of cDC and pDC of STAT2+/m (empty bars) and STAT2m/m (P117) (solid bars) mice was shown (n = 3). * P < 0.05 BM-derived pDC and cDC from STAT2+/m (empty bars) and STAT2m/m (P117) (solid bars) mice were enumerated and analyzed by flow cytometry and the cellularity (D) and the percentage (E) were determined. pDC (F) and cDC (G) of STAT2+/m (upper panels) and STAT2m/m (P117) (lower panels) were then stimulated without (left panels) or with LPS plus R848 (right panels) for overnight and stained with anti-MHC class II, followed by flow cytometry.
###end p 24
###begin p 25
###xml 67 69 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 92 101 92 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5D</xref>
###xml 165 167 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5E</xref>
###xml 232 236 232 236 <sup xmlns:xlink="http://www.w3.org/1999/xlink">m/m </sup>
###xml 274 278 274 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/m </sup>
###xml 348 352 348 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink">m/m </sup>
###xml 400 404 400 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/m </sup>
###xml 470 474 470 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink">m/m </sup>
###xml 498 502 498 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/m </sup>
###xml 582 586 582 586 <sup xmlns:xlink="http://www.w3.org/1999/xlink">m/m </sup>
###xml 602 606 602 606 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/m </sup>
###xml 616 618 616 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5F</xref>
###xml 707 711 707 711 <sup xmlns:xlink="http://www.w3.org/1999/xlink">m/m </sup>
###xml 790 794 790 794 <sup xmlns:xlink="http://www.w3.org/1999/xlink">m/m </sup>
###xml 864 866 864 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5G</xref>
###xml 947 951 947 951 <sup xmlns:xlink="http://www.w3.org/1999/xlink">m/m </sup>
###xml 1144 1148 1144 1148 <sup xmlns:xlink="http://www.w3.org/1999/xlink">m/m </sup>
###xml 237 241 <span type="species:ncbi:10090">P117</span>
###xml 278 282 <span type="species:ncbi:10090">mice</span>
###xml 353 357 <span type="species:ncbi:10090">P117</span>
###xml 359 363 <span type="species:ncbi:10090">mice</span>
###xml 404 408 <span type="species:ncbi:10090">mice</span>
###xml 475 479 <span type="species:ncbi:10090">P117</span>
###xml 587 591 <span type="species:ncbi:10090">P117</span>
###xml 712 716 <span type="species:ncbi:10090">P117</span>
###xml 795 799 <span type="species:ncbi:10090">P117</span>
###xml 952 956 <span type="species:ncbi:10090">P117</span>
###xml 1149 1153 <span type="species:ncbi:10090">P117</span>
It is reported that Flt3 signaling is important in DC development [24-26]. We first studied in vitro Flt3L-dependent DC development from BM. As shown in Fig. 5D and 5E, the numbers of pDC and cDC and the percentage of pDC from STAT2m/m (P117) were lower than that from STAT2+/m mice after Flt3L stimulation although the percentage of cDC from STAT2m/m (P117) mice was not different from that of STAT2+/m mice. Moreover, TLR ligand-induced MHC class II was lower in STAT2m/m (P117) pDC than in STAT2+/m pDC, although the basal level of MHC class II expression was comparable in STAT2m/m (P117) and STAT2+/m pDC (Fig. 5F). The effect of TLR ligands on MHC class II expression was even more pronounced in STAT2m/m (P117) cDC. While the basal level of MHC class II expression was lower in STAT2m/m (P117) cDC, its inducibility by TLR ligands was almost impaired (Fig. 5G). Experiments also show that the expression patterns of CD86 and ICAM-1 on STAT2m/m (P117) pDC and cDC were similar to that of MHC class II before and after TLR-ligand stimulation (data not shown). However, the aberrant response was observed only when DC was derived from STAT2m/m (P117) BM with Flt3L but not with GM-CSF stimulation (data not shown). These results suggest that STAT2 positively regulates Flt3L- but not GM-CSF -dependent DC development.
###end p 25
###begin title 26
###xml 0 4 <span type="species:ncbi:10090">P117</span>
P117 are sensitive to viral infection
###end title 26
###begin p 27
###xml 112 113 112 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 299 308 299 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 536 538 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 34 38 <span type="species:ncbi:10090">mice</span>
###xml 126 130 <span type="species:ncbi:10090">P117</span>
###xml 131 135 <span type="species:ncbi:10090">mice</span>
###xml 362 366 <span type="species:ncbi:10090">P117</span>
###xml 367 371 <span type="species:ncbi:10090">mice</span>
###xml 448 452 <span type="species:ncbi:12104?1.0">EMCV</span>
###xml 706 710 <span type="species:ncbi:10090">P117</span>
It has been previously shown that mice completely lacking STAT2 were extremely susceptible to viral infections [9]. Since the P117 mice still expressed a trace amount of functional STAT2, we wondered if the remaining STAT2 could confer antiviral response. First of all, we did antiviral state assay in vitro by pretreating MEFs cells from wild-type, STAT1KO and P117 mice with 2-fold serial dilution of IFNalpha starting from 1000 U/ml followed by EMCV infection at M.O.I. of 0.1 and scored the lytic activity in MEFs. As shown in Fig. 6A, IFNalpha induced wild-type MEF antiviral state in a dose-dependent manner. However, IFNalpha even at 1000 U/ml failed to induce antiviral effect on either STAT1KO or P117 MEFs.
###end p 27
###begin p 28
###xml 0 49 0 49 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Impaired antiviral response in P117 MEFs and mice</bold>
###xml 31 35 <span type="species:ncbi:10090">P117</span>
###xml 45 49 <span type="species:ncbi:10090">mice</span>
###xml 79 83 <span type="species:ncbi:10090">P117</span>
###xml 206 210 <span type="species:ncbi:12104?1.0">EMCV</span>
###xml 327 331 <span type="species:ncbi:10090">P117</span>
###xml 344 348 <span type="species:ncbi:10090">mice</span>
###xml 396 401 <span type="species:ncbi:10090">mouse</span>
###xml 405 409 <span type="species:ncbi:12104?1.0">EMCV</span>
###xml 503 507 <span type="species:ncbi:10090">mice</span>
###xml 521 525 <span type="species:ncbi:10090">mice</span>
Impaired antiviral response in P117 MEFs and mice. (A) Wild-type, STAT1KO, and P117 MEFs were pretreated with 2-fold serial dilution of IFNalpha starting from 1000 U/ml for 24 h, followed by infection with EMCV at a M.O.I of 0.1. Live cells were visualized with crystal violet 18 h after the infection. Wild-type (squares) and P117 (triangles) mice were i.p. injected with 0.2 (B) or 200 (C) pfu/mouse of EMCV and survival rate was recorded every day for 7 days. Numbers in parenthesis represented live mice versus total mice at the end of the experiment.
###end p 28
###begin p 29
###xml 32 41 32 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 63 70 63 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 395 397 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6C</xref>
###xml 406 409 406 409 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50 </sub>
###xml 86 90 <span type="species:ncbi:10090">P117</span>
###xml 91 95 <span type="species:ncbi:10090">mice</span>
###xml 125 129 <span type="species:ncbi:12104?1.0">EMCV</span>
###xml 174 178 <span type="species:ncbi:10090">P117</span>
###xml 179 183 <span type="species:ncbi:10090">mice</span>
###xml 237 241 <span type="species:ncbi:12104?1.0">EMCV</span>
###xml 263 267 <span type="species:ncbi:10090">mice</span>
###xml 346 350 <span type="species:ncbi:10090">mice</span>
###xml 375 379 <span type="species:ncbi:12104?1.0">EMCV</span>
###xml 412 416 <span type="species:ncbi:12104?1.0">EMCV</span>
###xml 421 425 <span type="species:ncbi:10090">P117</span>
###xml 426 430 <span type="species:ncbi:10090">mice</span>
###xml 485 489 <span type="species:ncbi:10090">mice</span>
###xml 517 521 <span type="species:ncbi:10090">P117</span>
###xml 522 526 <span type="species:ncbi:10090">mice</span>
###xml 556 560 <span type="species:ncbi:12104?1.0">EMCV</span>
###xml 633 637 <span type="species:ncbi:10090">P117</span>
###xml 638 642 <span type="species:ncbi:10090">mice</span>
###xml 742 746 <span type="species:ncbi:10090">P117</span>
###xml 777 781 <span type="species:ncbi:10090">mice</span>
The impaired antiviral response in vitro was further confirmed in vivo. Wild-type and P117 mice were given 0.2 or 200 PFU of EMCV intraperitoneally. As shown in Fig. 6B, all P117 mice died within 2-4 days after infection with 0.2 pfu of EMCV, while all wild-type mice survived. The protective effect of STAT2 was obvious as only 1/3 of wild-type mice succumbed to 200 PFU of EMCV by day 7 (Fig. 6C). The LD50 of EMCV for P117 mice was, at least, 1000-fold lower than that of wild-type mice. Our work also showed that P117 mice were susceptible not only to EMCV but also to VSV infection (data not shown). These results indicate that P117 mice were extremely susceptible to viral infections and that the level of functional STAT2 expressed in P117 was not sufficient to protect mice from infection of different viruses.
###end p 29
###begin title 30
Discussion
###end title 30
###begin p 31
###xml 80 84 <span type="species:ncbi:10090">mice</span>
###xml 683 687 <span type="species:ncbi:10090">mice</span>
###xml 1020 1025 <span type="species:ncbi:9606">human</span>
###xml 1029 1034 <span type="species:ncbi:10090">mouse</span>
We reported here the identification and characterization of the ENU-mutagenized mice p117 that displayed impaired response to type I, but not type II, IFNs. Inheritance test indicates that the deviant phenotype was recessive. Rough genetic mapping suggests that the mutation accounted for the phenotypes is linked to chromosome 10. Genomic and cDNA sequencing further confirmed a T to A point mutation located in the 5' splice site of intron 4-5 of STAT2 gene which leads to cryptic splicing and addition of 5 extra nucleotides between exon 4 and 5, causing frame shift and generation of stop codons. As a result, the expression of STAT2 protein was greatly diminished in the mutant mice. Three lines of evidence suggest that the mutation in STAT2 is highly likely the cause of the phenotypes seen in this pedigree. First of all, STAT2 only participates in type I, but not type II, IFN response. Secondly, STAT2 gene is located in the chromosome 10 which is in line with the genetic mapping. Thirdly, the restoration of human or mouse STAT2 in mutant cells rescues IFNalpha response.
###end p 31
###begin p 32
###xml 219 221 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 222 224 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 809 811 805 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 991 993 987 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1112 1114 1104 1106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1228 1229 1220 1221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 39 43 <span type="species:ncbi:10090">mice</span>
###xml 89 94 <span type="species:ncbi:9606">human</span>
###xml 267 273 <span type="species:ncbi:9606">humans</span>
###xml 315 320 <span type="species:ncbi:9606">human</span>
###xml 325 330 <span type="species:ncbi:10090">mouse</span>
###xml 581 587 <span type="species:ncbi:9606">humans</span>
###xml 599 603 <span type="species:ncbi:10090">mice</span>
###xml 718 723 <span type="species:ncbi:10090">mouse</span>
###xml 867 871 <span type="species:ncbi:10090">mice</span>
###xml 894 899 <span type="species:ncbi:10090">mouse</span>
###xml 911 916 <span type="species:ncbi:9606">human</span>
###xml 1023 1028 <span type="species:ncbi:10090">mouse</span>
###xml 1038 1043 <span type="species:ncbi:9606">human</span>
###xml 1160 1165 <span type="species:ncbi:9606">human</span>
###xml 1175 1180 <span type="species:ncbi:10090">mouse</span>
###xml 1181 1185 <span type="species:ncbi:10090">P117</span>
###xml 1370 1375 <span type="species:ncbi:9606">human</span>
###xml 1380 1385 <span type="species:ncbi:10090">mouse</span>
Among the seven STAT family members in mice, STAT2 is relatively special compared to its human counterpart because of the insertion of a sequence containing 6 tandem copies of a 16 amino acid repeats at its C-terminus [20,21]. Because this sequence is not present in humans, it greatly reduces the homology between human and mouse to less than 40% in TAD domain. It was speculated that these repeats might mediate interactions with species-specific proteins that are important for the biology of STAT2. Indeed, Farrar et al. reported that type I IFNs induce Th1 differentiation in humans but not in mice by activating STAT4 and recruiting to the IFNalpha receptor complex via the C-terminus of STAT2. The insertion in mouse STAT2 alters the C-terminus and selectively disrupts its capacity to activate STAT4 [27]. However, this notion was negated by the finding that mice expressing a chimeric mouse STAT2 with human TAD domain were unable to activate STAT4 and trigger Th1 differentiation [28]. In fact, overexpression of mouse STAT2 in human U6 cell line that does not express STAT2 rescues IFNalpha response [21]. Here we also showed that the expression of human STAT2 in mouse P117 MEFs was able to correct the defect (Fig. 4). These data suggest that highly divergent primary sequences can serve similar functions and that the minimal regions of similarity between human and mouse STAT2 may define the critical regions for its function.
###end p 32
###begin p 33
###xml 273 275 273 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 353 362 353 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 554 562 554 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1036 1038 1032 1034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1119 1128 1115 1124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1132 1139 1128 1135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1330 1332 1326 1328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1613 1617 1601 1605 <sup xmlns:xlink="http://www.w3.org/1999/xlink">m/m </sup>
###xml 1648 1652 1636 1640 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/m </sup>
###xml 1680 1689 1668 1677 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1839 1840 1827 1828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 1914 1916 1902 1904 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1932 1934 1920 1922 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 2086 2088 2074 2076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 109 122 <span type="species:ncbi:11234">measles virus</span>
###xml 124 126 <span type="species:ncbi:11234">MV</span>
###xml 131 165 <span type="species:ncbi:11623">lymphocytic choriomeningitis virus</span>
###xml 167 171 <span type="species:ncbi:11623?0.9953846153846154">LCMV</span>
###xml 278 280 <span type="species:ncbi:11234">MV</span>
###xml 290 295 <span type="species:ncbi:10090">mouse</span>
###xml 436 440 <span type="species:ncbi:10090">mice</span>
###xml 451 455 <span type="species:ncbi:11623?0.9953846153846154">LCMV</span>
###xml 659 663 <span type="species:ncbi:10090">mice</span>
###xml 852 856 <span type="species:ncbi:10090">mice</span>
###xml 1050 1055 <span type="species:ncbi:10090">mouse</span>
###xml 1289 1293 <span type="species:ncbi:10090">mice</span>
###xml 1324 1328 <span type="species:ncbi:10090">mice</span>
###xml 1618 1622 <span type="species:ncbi:10090">P117</span>
###xml 1624 1628 <span type="species:ncbi:10090">mice</span>
###xml 1665 1669 <span type="species:ncbi:10090">mice</span>
###xml 1828 1832 <span type="species:ncbi:10090">mice</span>
###xml 1903 1908 <span type="species:ncbi:9606">human</span>
###xml 1922 1927 <span type="species:ncbi:10090">mouse</span>
The roles of type I IFNs in DC development and maturation are still controversial. Hahm et al. reported that measles virus (MV) or lymphocytic choriomeningitis virus (LCMV) evades immune system by interfering DC development and expansion through generation of type I IFNs [29]. MV-infected mouse BM cells secrete soluble factors, including type I IFNs, in vitro to inhibit DC development from BM of wild-type or STAT1KO but not STAT2KO mice. Besides, LCMV cl13, which induces systemic type I IFN production during infection, interferes with DC expansion in vivo and reduces the frequency of DC progenitor cells within BM of wild-type, STAT1KO but not STAT2KO mice. These results suggest that type I IFNs negatively regulate DC development in a STAT2-dependent but STAT1-independent manner during viral infection. However, in IFNalpha receptor knockout mice (IFNARKO), the expression of costimulatory molecules or MHC class I and class II in GM-CSF-derived DC was reduced, so was the proliferating ability of T cells induced by the DCs [30]. Besides, mouse DCs undergo phenotypic maturation upon exposure to type I IFNs in vitro and in vivo. Recently, Trinchieri's group reported that the TLR ligand-mediated induction of CD40 and CD86 was greatly reduced in splenic pDC and cDC of IFNARKO mice compared to that of wild-type mice [31]. Since IFNalpha was induced in splenic DCs upon TLR ligand stimulation, these results also suggest that IFNalpha may participate in a positive feedback regulation of the maturation of DCs. Here, we showed a significant reduction of the percentages of splenic pDC and cDC in STAT2m/m (P117) mice as opposed to STAT2+/m or wild-type mice. Besides, in vitro assays also showed that Flt3L-dependent DC development and TLR ligand-mediated DC differentiation were also defective in cells from mutant mice (Fig. 5). In fact, gene profiling using DNA microarray has shown that human BDCA4+ DC or mouse B220+ plasmacytoid DC are among the highest expressers of STAT2 mRNA in different tissues and cells, indicating a physiological requirement of STAT2 for DCs [32]. Taken together, these results suggest a positively regulatory role of type I IFN and STAT2 in DC development.
###end p 33
###begin p 34
###xml 138 147 134 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 201 209 197 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 215 216 211 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 310 311 306 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 312 313 308 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1221 1223 1213 1215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 1990 1991 1970 1971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1992 1994 1972 1974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 1995 1997 1975 1977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 39 43 <span type="species:ncbi:10090">P117</span>
###xml 44 48 <span type="species:ncbi:10090">mice</span>
###xml 179 183 <span type="species:ncbi:12104?1.0">EMCV</span>
###xml 304 308 <span type="species:ncbi:10090">mice</span>
###xml 421 425 <span type="species:ncbi:10090">P117</span>
###xml 426 430 <span type="species:ncbi:10090">mice</span>
###xml 526 530 <span type="species:ncbi:10090">P117</span>
###xml 531 535 <span type="species:ncbi:10090">mice</span>
###xml 663 667 <span type="species:ncbi:10090">mice</span>
###xml 695 699 <span type="species:ncbi:12104?1.0">EMCV</span>
###xml 760 764 <span type="species:ncbi:10090">mice</span>
###xml 797 801 <span type="species:ncbi:10090">mice</span>
###xml 928 932 <span type="species:ncbi:10090">P117</span>
###xml 933 937 <span type="species:ncbi:10090">mice</span>
###xml 1075 1079 <span type="species:ncbi:10090">P117</span>
###xml 1080 1084 <span type="species:ncbi:10090">mice</span>
###xml 1282 1286 <span type="species:ncbi:10090">mice</span>
###xml 1644 1648 <span type="species:ncbi:10090">P117</span>
###xml 1861 1865 <span type="species:ncbi:10090">P117</span>
###xml 1978 1982 <span type="species:ncbi:10090">P117</span>
###xml 2042 2046 <span type="species:ncbi:10090">mice</span>
Other than impaired IFNalpha response, P117 mice or cells were also sensitive to viral infections as indicated by reduced antiviral state in vitro and increased susceptibility to EMCV or VSV infection in vivo (Fig. 5 and data not shown). These phenotypes were very much reminiscent of STAT1KO or STAT2KO mice [7-9] in which type I IFN response is also impaired. There are similarities and differences between STAT2KO and P117 mice. In terms of gene expression, in general, the macrophages or splenocytes from both STAT2KO and P117 mice showed impaired response to type I IFNs while the response to type II IFN was intact. As for antiviral response, both types of mice are susceptible to VSV and EMCV infections, judging from increased viral burdens in STAT2KO mice and increased lethality in both mice. However, it still remains to be determined if the susceptibility to viral infection is comparable or not between STAT2KO and P117 mice. Nonetheless, there are also differences between these two systems. First of all, a trace amount of functional STAT2 is still present in P117 mice and it is capable of transducing signals to induce the expression of downstream OAS gene and STAT2 itself in response to IFNalpha (Fig. 3C). STAT2 protein is, however, completely devoid in STAT2KO mice and, therefore, there is a lack of ISGF3-mediated signaling in STAT2KO cells in response to IFNalpha. Secondly, basal level of STAT1 protein is reduced in STAT2KO MEF, which resulted in a block of type I IFN-dependent induction of MHC class I and impaired IFNgamma-mediated antiviral response. We, however, did not observe any reduction of STAT1 protein in P117 MEF (data not shown) although the response to IFNgamma has yet to be determined. The differential expression of basal level of STAT1 protein in these MEFs may lie in the presence of the residual STAT2 protein in P117 MEF, which may trigger a type I IFN-dependent autocrine loop to maintain the basal level of STAT1 expression in P117 cells [9,33-35]. Nonetheless, susceptibility of the mutant mice to viral infections also indicates that the residual STAT2 is not sufficient to mount an antiviral response and there is a threshold requirement of STAT2 for type I IFNs to be fully functional.
###end p 34
###begin title 35
Materials and methods
###end title 35
###begin title 36
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice and cells
###end title 36
###begin p 37
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 262 266 262 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink">m/m </sup>
###xml 279 282 279 282 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/m</sup>
###xml 16 20 <span type="species:ncbi:10090">mice</span>
###xml 43 48 <span type="species:ncbi:10090">Mouse</span>
###xml 145 149 <span type="species:ncbi:10090">mice</span>
###xml 178 182 <span type="species:ncbi:10090">P117</span>
###xml 183 187 <span type="species:ncbi:10090">mice</span>
###xml 267 271 <span type="species:ncbi:10090">P117</span>
###xml 309 313 <span type="species:ncbi:10090">mice</span>
###xml 337 341 <span type="species:ncbi:10090">mice</span>
###xml 513 517 <span type="species:ncbi:10090">P117</span>
ENU-mutagenized mice were generated in the Mouse Mutagenesis Program Core Facility (MMPCF) at the Academia Sinica, Taiwan. The generation of ENU mice was done as described [36]. P117 mice were bred in C57BL/6J background. In this study, we use 6~8 week-old STAT2m/m (P117), STAT2+/m, and wild-type littermate mice to do experiments. All mice are housed in the SPF environment at the NTUMC Animal Core Facility and the protocol was approved by the Institutional Animal Care and Use Committee at NTU. Generation of P117 embryonic fibroblasts (MEF) was done as described in the Current Protocols in Molecular Biology Unit 28.1. Primary MEFs were spontaneously immortalized by passaging the cells till they passed crisis. wild-type and STAT1KO MEF cell lines were provided by Dr. David Levy at New York University Medical Center Department of Pathology.
###end p 37
###begin title 38
Interval haplotype analysis
###end title 38
###begin p 39
###xml 55 57 55 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 164 169 <span type="species:ncbi:10090">mouse</span>
###xml 307 311 <span type="species:ncbi:10090">mice</span>
###xml 315 319 <span type="species:ncbi:10090">P117</span>
###xml 450 454 <span type="species:ncbi:10090">mice</span>
###xml 508 512 <span type="species:ncbi:10090">mice</span>
The interval haplotype analysis was done as described [19]. Briefly, genotype of a proximal and a distal marker for 21 chromosomal intervals distributed across the mouse genome (corresponding to two intervals for Chromosomes 1 and 2 and one for the remaining 17 autosomes) were used to do haplotyping. Male mice of P117 (C57BL/6 genetic background) were mated with C3H/HeJ females to generated F1 offspring that were then intercrossed to generate F2 mice. DNA samples obtained from 15 individual affected F2 mice were then subjected to interval haplotype analysis.
###end p 39
###begin title 40
Flow cytometry
###end title 40
###begin p 41
###xml 353 358 353 358 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 367 372 367 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 398 403 398 403 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 412 417 412 417 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 443 448 443 448 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 457 462 457 462 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
Cells stimulated without or with IFNs were stained with fluorescence conjugated antibodies and subjected to flow cytometry analysis using FCASCanto (BD Biosciences). Antibodies used were the follows CD11b-FITC, CD11c-APC, B220-PE/FITC, CD86-PE/FITC, MHC I-FITC and ICAM-1-APC (all from e-bioscience). Stimulation index was calculated as follows (% MHC Ihigh or ICAM-1high after treatment - % MHC I high or ICAM-1high before treatment)/% MHC I high or ICAM-1high before treatment.
###end p 41
###begin title 42
Real-time RT-QPCR
###end title 42
###begin p 43
mRNA of PBL before and after IFN treatment was prepared using TurboCapture 96 mRNA kit (Qiagen) according to manufacturer's instructions. In some experiments, TRIzol reagent (Invitrogen) was used to prepare total RNA of splenocytes. One to three mug total RNAs prepared from cells treated with 250 U/ml IFNalpha (Merck) or 50 ng/ml IFNgamma (Peprotech) for indicated times were subjected to reverse transcription. Quantitative real-time PCRs were carried out on the iCycler iQ real-time detection system (Bio-Rad). Each sample was performed in duplicates. The primer sequences used for PCR are the follows.
###end p 43
###begin p 44
beta-actin Forward 5'-AGGGAAATCGTGCGTGAC-3'
###end p 44
###begin p 45
Reverse 5'-GCTCGTTGCCAATAGTGATG-3'
###end p 45
###begin p 46
IP-10 Forward 5'-TGAGCAGAGATGTCTGAATCCG-3'
###end p 46
###begin p 47
Reverse 5'-TGTCCATCCATCGCAGCA-3'
###end p 47
###begin p 48
OAS Forward 5'-GCCATTGCACGCTCGCCTACTAC-3'
###end p 48
###begin p 49
Reverse 5'-CTCCTGCCATCCGGGTTTTTCA-3'
###end p 49
###begin p 50
PKR Forward 5'-TGCGCAGACAATGTATGGTAC-3'
###end p 50
###begin p 51
Reverse 5'-ATGTGACAACGCTAGAGGATG-3'
###end p 51
###begin p 52
SOCS1 Forward 5'-CCTGGTTGTAGCAGCTTGT-3'
###end p 52
###begin p 53
Reverse 5'-CGACCCCTGGTTTGTGCAA-3'
###end p 53
###begin title 54
Western blotting
###end title 54
###begin p 55
###xml 344 350 <span type="species:ncbi:9986">rabbit</span>
Total cell lysates of splenocytes or MEFs that were treated without or with IFN (IFNgamma 50 ng/ml or IFNalpha 250 U/ml) for indicated times were subjected to electrophoresis. After transferring to nitrocellulose membrane, antibodies to tubulin (Sigma), phospho-STAT1 (tyrosine 701, Zymed), phospho-STAT2 (tyrosine 689, Upstate), and home-made rabbit antibodies to STATI and STAT2 were used for blotting.
###end p 55
###begin title 56
Retroviral transduction
###end title 56
###begin p 57
###xml 63 65 63 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 120 125 <span type="species:ncbi:10090">mouse</span>
###xml 129 134 <span type="species:ncbi:9606">human</span>
Transduction of retroviruses into MEFs were done as described [37]. Briefly, a bicistronic retroviral vector containing mouse or human STAT2 cDNA and GFP was co-transfected with a plasmid expressing VSV G into 293T cells for 2 days before collecting the virus supernatant. MEFs were incubated with the virus supernatant in the presence of 8 mug/ml polybrene and spun at 1100 g for 90 min at 30degreesC. Flow cytometry were performed to measure GFP expression as an indicator of transduction efficiency in MEFs 2 days after the infection.
###end p 57
###begin title 58
In vitro culture of DCs
###end title 58
###begin p 59
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
###xml 83 85 83 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 103 105 103 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7 </sup>
###xml 461 462 456 457 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 467 468 462 463 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 472 473 467 468 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 489 490 484 485 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 495 496 490 491 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 500 501 495 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 197 202 <span type="species:ncbi:10090">mouse</span>
In vitro culture of DCs was done as described previously with slight modification [38]. Briefly, 1 x 107 BM cells were cultured in 10 ml of 10% FBS containing RPMI-1640 supplemented with 100 ng/ml mouse Flt3L (Peprotech), 50 muM beta-ME (Sigma) and 50 mug/ml Gentamicin (Invitrogen) for 8 days. Different subsets of DCs were identified by staining the cells with anti-CD11c-APC, anti-CD11b-FITC and anti-B220-PE antibodies followed by flow cytometry. pDC (CD11c+CD11b-B220+) and cDC (CD11c+CD11b+B220-) were then sorted using FACSAria (BD Biosciences) and rested for 1 day before being stimulated with LPS 0.1 mug/ml plus R848 1 mug/ml for overnight and measured the expression of MHC class II using anti-I-A/I-E-PE antibody (Biolegend) to stain cells and measured by flow cytometry.
###end p 59
###begin title 60
In vitro and in vivo antiviral assays
###end title 60
###begin p 61
###xml 4 13 4 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 558 566 548 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 43 47 <span type="species:ncbi:10090">P117</span>
###xml 144 148 <span type="species:ncbi:12104?1.0">EMCV</span>
###xml 587 591 <span type="species:ncbi:10090">P117</span>
###xml 592 596 <span type="species:ncbi:10090">mice</span>
###xml 631 636 <span type="species:ncbi:10090">mouse</span>
###xml 640 644 <span type="species:ncbi:12104?1.0">EMCV</span>
For in vitro assay, wild-type, STAT1KO, or P117 MEFs were pretreated with 2-fold serial dilution of IFNalpha (1000 U/ml to 0.98 U/ml) for 24 h. EMCV at a M.O.I of 0.1 was added in serum free DMEM medium for 45 min 37degreesC. Viral supernatant was removed and the cells were refreshed with complete medium. Eighteen hours post-infection, medium was removed and cells were fixed with 10% formaldehyde solution for 20 min at RT. After fixation, cells were visualized with crystal violet. The excessive dye was then removed by immersing the plate in water. For in vivo assay, wild-type and P117 mice were infected with 0.2 or 200 pfu/mouse of EMCV by intraperitoneal injection. The survival rate was recorded every 24 h for 7 days.
###end p 61
###begin title 62
Statistics
###end title 62
###begin p 63
###xml 0 12 0 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Student's T </italic>
Student's T test (two-tailed) was used for statistical analysis.
###end p 63
###begin title 64
Competing interests
###end title 64
###begin p 65
The authors declare that they have no competing interests.
###end p 65
###begin title 66
Authors' contributions
###end title 66
###begin p 67
LSC did the biochemical analysis, RT-QPCR and antiviral assays. PCW did the screening, inheritance test and identified the mutation. TL did the sequencing and flow cytometry. CHK did the sequencing and flow cytometry. LMP did immunohistochemical staining for tissue sections. CKL designed the experiments, helped to coordinate and drafted the manuscript.
###end p 67
###begin title 68
Acknowledgements
###end title 68
###begin p 69
###xml 87 91 <span type="species:ncbi:10090">mice</span>
###xml 218 223 <span type="species:ncbi:10090">Mouse</span>
###xml 299 303 <span type="species:ncbi:10090">mice</span>
We thank Dr. John Kung for helpful discussions during screening of the ENU-mutagenized mice, Dr. David Levy for providing reagents and Dr. Betty Wu-Hsieh for critical reading on the manuscript. We are grateful for the Mouse Mutagenized Program Core Facility at Academia Sinica for providing the ENU mice and the service for genetic mapping. The grants were supported by the National Science Council, Taiwan (NSC 95- 95-3112-B-002-030 and 96-3112-B-002-029).
###end p 69
###begin article-title 70
Interferon-inducible antiviral effectors
###end article-title 70
###begin article-title 71
Cellular responses to interferon-gamma
###end article-title 71
###begin article-title 72
Type I interferons in host defense
###end article-title 72
###begin article-title 73
IFN-gamma: recent advances in understanding regulation of expression, biological functions, and clinical applications
###end article-title 73
###begin article-title 74
Interferons, immunity and cancer immunoediting
###end article-title 74
###begin article-title 75
JAK-STAT signaling: from interferons to cytokines
###end article-title 75
###begin article-title 76
###xml 27 32 <span type="species:ncbi:10090">mouse</span>
Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease
###end article-title 76
###begin article-title 77
###xml 41 45 <span type="species:ncbi:10090">mice</span>
Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway
###end article-title 77
###begin article-title 78
###xml 34 38 <span type="species:ncbi:10090">mice</span>
Immune response in Stat2 knockout mice
###end article-title 78
###begin article-title 79
Distinct requirements for IFNs and STAT1 in NK cell function
###end article-title 79
###begin article-title 80
Stat1-dependent synergistic activation of T-bet for IgG2a production during early stage of B cell activation
###end article-title 80
###begin article-title 81
###xml 27 32 <span type="species:ncbi:10090">mouse</span>
Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality
###end article-title 81
###begin article-title 82
What does Stat3 do?
###end article-title 82
###begin article-title 83
STAT3 positively regulates an early step in B-cell development
###end article-title 83
###begin article-title 84
STAT3 is a negative regulator of granulopoiesis but is not required for G-CSF-dependent differentiation
###end article-title 84
###begin article-title 85
IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways
###end article-title 85
###begin article-title 86
ENU mutagenesis, a way forward to understand gene function
###end article-title 86
###begin article-title 87
ENU-mutagenesis: insight into immune function and pathology
###end article-title 87
###begin article-title 88
Efficient localization by internal haplotype analysis
###end article-title 88
###begin article-title 89
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
Murine Stat2 is uncharacteristically divergent
###end article-title 89
###begin article-title 90
Stat protein transactivation domains recruit p300/CBP through widely divergent sequences
###end article-title 90
###begin article-title 91
Natural adjuvants: endogenous activators of dendritic cells
###end article-title 91
###begin article-title 92
Type I IFNs enhance the terminal differentiation of dendritic cells
###end article-title 92
###begin article-title 93
STAT3 is required for Flt3L-dependent dendritic cell differentiation
###end article-title 93
###begin article-title 94
Flt3 in regulation of type I interferon-producing cell and dendritic cell development
###end article-title 94
###begin article-title 95
Development of dendritic-cell lineages
###end article-title 95
###begin article-title 96
###xml 100 105 <span type="species:ncbi:10090">mouse</span>
Selective loss of type I interferon-induced STAT4 activation caused by a minisatellite insertion in mouse Stat2
###end article-title 96
###begin article-title 97
###xml 75 81 <span type="species:ncbi:10090">murine</span>
###xml 117 123 <span type="species:ncbi:10090">murine</span>
###xml 124 129 <span type="species:ncbi:9606">human</span>
IL-12, but not IFN-alpha, promotes STAT4 activation and Th1 development in murine CD4+ T cells expressing a chimeric murine/human Stat2 gene
###end article-title 97
###begin article-title 98
Viruses evade the immune system through type I interferon-mediated STAT2-dependent, but STAT1-independent, signaling
###end article-title 98
###begin article-title 99
Type I interferons produced by dendritic cells promote their phenotypic and functional activation
###end article-title 99
###begin article-title 100
Type I interferon dependence of plasmacytoid dendritic cell activation and migration
###end article-title 100
###begin article-title 101
###xml 20 25 <span type="species:ncbi:10090">mouse</span>
###xml 30 35 <span type="species:ncbi:9606">human</span>
A gene atlas of the mouse and human protein-encoding transcriptomes
###end article-title 101
###begin article-title 102
Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7
###end article-title 102
###begin article-title 103
Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7
###end article-title 103
###begin article-title 104
Cross talk between interferon-gamma and -alpha/beta signaling components in caveolar membrane domains
###end article-title 104
###begin article-title 105
###xml 53 58 <span type="species:ncbi:10090">mouse</span>
Optimal N-ethyl-N-nitrosourea (ENU) doses for inbred mouse strains
###end article-title 105
###begin article-title 106
Differential regulation of constitutive major histocompatibility complex class I expression in T and B lymphocytes
###end article-title 106
###begin article-title 107
###xml 14 20 <span type="species:ncbi:10090">murine</span>
Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures
###end article-title 107

